These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12357001)

  • 1. Assessing pneumococcal revaccination safety among New York State Medicare beneficiaries.
    Shih A; Quinley J; Lee TK; Messina CR
    Public Health Rep; 2002; 117(2):164-73. PubMed ID: 12357001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults.
    Musher DM; Manof SB; Liss C; McFetridge RD; Marchese RD; Bushnell B; Alvarez F; Painter C; Blum MD; Silber JL
    J Infect Dis; 2010 Feb; 201(4):516-24. PubMed ID: 20092407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there any connection between a second pneumonia shot and hospitalization among Medicare beneficiaries?
    Snow R; Babish JD; McBean AM
    Public Health Rep; 1995; 110(6):720-5. PubMed ID: 8570826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of revaccination with pneumococcal polysaccharide vaccine.
    Jackson LA; Benson P; Sneller VP; Butler JC; Thompson RS; Chen RT; Lewis LS; Carlone G; DeStefano F; Holder P; Lezhava T; Williams WW
    JAMA; 1999 Jan; 281(3):243-8. PubMed ID: 9918479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumococcal vaccination of the elderly during visits to acute care providers: who are vaccinated?
    Sabapathy D; Strong D; Myers R; Li B; Quan H
    Prev Med; 2014 May; 62():155-60. PubMed ID: 24246965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged 65 > or = years.
    Manoff SB; Liss C; Caulfield MJ; Marchese RD; Silber J; Boslego J; Romero-Steiner S; Rajam G; Glass NE; Whitney CG; Carlone GM
    J Infect Dis; 2010 Feb; 201(4):525-33. PubMed ID: 20088694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumococcal polysaccharide 23-valent vaccine: long-term persistence of circulating antibody and immunogenicity and safety after revaccination in adults.
    Grabenstein JD; Manoff SB
    Vaccine; 2012 Jun; 30(30):4435-44. PubMed ID: 22542818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the introduction of pneumococcal conjugate vaccine on immunization coverage among infants.
    Lin ND; Kleinman K; Chan KA; Yu XJ; France EK; Xu S; Wei F; Mullooly J; Santoli J; Lieu TA;
    BMC Pediatr; 2005 Nov; 5():43. PubMed ID: 16313673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of conjugate pneumococcal vaccination on routine childhood vaccination and primary care use in 2 counties.
    Szilagyi PG; Griffin MR; Shone LP; Barth R; Zhu Y; Schaffer S; Ambrose S; Roy J; Poehling KA; Edwards KM; Walker FJ; Schwartz B;
    Pediatrics; 2006 Oct; 118(4):1394-402. PubMed ID: 17015528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised revaccination with pneumococcal polysaccharide or conjugate vaccine in asplenic children previously vaccinated with polysaccharide vaccine.
    Smets F; Bourgois A; Vermylen C; Brichard B; Slacmuylders P; Leyman S; Sokal E
    Vaccine; 2007 Jul; 25(29):5278-82. PubMed ID: 17576024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of pneumococcal vaccination with hospitalization and mortality in hemodialysis patients.
    Gilbertson DT; Guo H; Arneson TJ; Collins AJ
    Nephrol Dial Transplant; 2011 Sep; 26(9):2934-9. PubMed ID: 21317410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of quadrivalent human papillomavirus vaccine administered routinely to females.
    Klein NP; Hansen J; Chao C; Velicer C; Emery M; Slezak J; Lewis N; Deosaransingh K; Sy L; Ackerson B; Cheetham TC; Liaw KL; Takhar H; Jacobsen SJ
    Arch Pediatr Adolesc Med; 2012 Dec; 166(12):1140-8. PubMed ID: 23027469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revaccination with 7-valent pneumococcal conjugate vaccine elicits better serologic response than 23-valent pneumococcal polysaccharide vaccine in HIV-infected adult patients who have undergone primary vaccination with 23-valent pneumococcal polysaccharide vaccine in the era of combination antiretroviral therapy.
    Lu CL; Chang SY; Chuang YC; Liu WC; Su CT; Su YC; Chang SF; Hung CC
    Vaccine; 2014 Feb; 32(9):1031-5. PubMed ID: 24440112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A questionnaire study on the necessity of approval for revaccination of the pneumococcal polysaccharide vaccine].
    Oishi K; Kawakami K; Nagai H; Sunakawa K; Watanabe A
    Nihon Kokyuki Gakkai Zasshi; 2010 Jan; 48(1):5-9. PubMed ID: 20163014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of reaching the drug benefit threshold on Medicare members' healthcare utilization during the first year of Medicare Part D.
    Raebel MA; Delate T; Ellis JL; Bayliss EA
    Med Care; 2008 Oct; 46(10):1116-22. PubMed ID: 18815534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of pneumococcal revaccination.
    Rodriguez R; Dyer PD
    J Gen Intern Med; 1995 Sep; 10(9):511-2. PubMed ID: 8523154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital and emergency department utilization associated with treatment for chronic obstructive pulmonary disease in a managed-care Medicare population.
    Simoni-Wastila L; Yang HW; Blanchette CM; Zhao L; Qian J; Dalal AA
    Curr Med Res Opin; 2009 Nov; 25(11):2729-35. PubMed ID: 19778165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained functional serotype-specific antibody after primary and secondary vaccinations with a pneumococcal polysaccharide vaccine in elderly patients with chronic lung disease.
    Ohshima N; Nagai H; Matsui H; Akashi S; Makino T; Akeda Y; Oishi K
    Vaccine; 2014 Feb; 32(10):1181-6. PubMed ID: 24120483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactions after 3 or more doses of pneumococcal polysaccharide vaccine in adults in Alaska.
    Walker FJ; Singleton RJ; Bulkow LR; Strikas RA; Butler JC
    Clin Infect Dis; 2005 Jun; 40(12):1730-5. PubMed ID: 15909258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation.
    Patel SR; Ortín M; Cohen BJ; Borrow R; Irving D; Sheldon J; Heath PT
    Clin Infect Dis; 2007 Mar; 44(5):625-34. PubMed ID: 17278051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.